The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.

Clicks: 348
ID: 106908
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
: Visceral leishmaniasis (VL) is a vector-borne disease caused by or . Closely related to poverty, VL is fatal and represents one of the main burdens on public health in developing countries. Treatment of VL relies exclusively on chemotherapy, a strategy still experiencing numerous limitations. Miltefosine (MF) has been used in the chemotherapy of VL in some endemic areas, and has been expanded to other regions, being considered crucial in eradication programs.: This article reviews the most relevant preclinical and clinical aspects of MF, its mechanism of action and resistance to parasites, as well as its limitations. The authors also give their perspectives on the treatment of VL.: The discovery of MF represented an enormous advance in the chemotherapy of VL, since it was the first oral drug for this neglected disease. Beyond selection of resistant parasites due to drug pressure, several other factors can lead to treatment failure such as, for example, factors intrinsic to the host, parasite and the drug itself. Although its efficacy as a monotherapy has reduced over recent years, MF is still an important alternative in VL chemotherapy, especially when used in combination with other drugs.
Reference Key
reimo2020theexpert Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Reimão, Juliana Q;Pita Pedro, Débora P;Coelho, Adriano C;
Journal expert opinion on drug discovery
Year 2020
DOI
10.1080/17460441.2020.1743674
URL
Keywords
pharmacokinetics pharmacodynamics mechanism of action leishmania donovani visceral leishmaniasis leishmania infantum clinical pharmacology alkyl-phosphocholine miltefosine preclinical pharmacology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.